The role of angiotensin-converting enzyme in blood pressure control, renal function, and male fertility

Trends in Endocrinology and Metabolism

Volumn 8, Issue 5, 1997, Pages 181-186

  Esther Jr , Charles R ^a   Marino, Elaine M ^a   Bernstein, Kenneth E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; BLOOD PRESSURE REGULATION; ENZYME ACTIVITY; ENZYME ASSAY; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; MALE; MALE FERTILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0343471959     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(97)00039-8     Document Type: Review

References (56)

1. Azizi M, Rousseau A, Ezan E, et al.: 1996. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 97:839-844.
2. Bakhle YS: 1968. Conversion of angiotensin-I to angiotensin-II by cell-free extracts of dog lung. Nature 220:919-921.
3. Beldent V, Michaud A, Wei L, Chauvet MT, Corvol P: 1993. Proteolytic release of human angiotensin-converting enzyme: localization of the cleavage site. J Biol Chem 268:26,428-26,434.
4. Bernstein KE, Berk BC: 1993. The biology of angiotensin II receptors. Am J Kidney Dis 22:745-754.
5. Bernstein KE, Martin BM, Edwards AS, Bernstein EA: 1989. Mouse angiotensin I-converting enzyme is a protein composed of two homologous domains. J Biol Chem 264: 11,945-11,951.
6. Blendy JA, Kaestner KH, Weinbauer GF, Nieschlag E, Schutz G: 1996. Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature 380:162-165.
7. Bunning P, Riordan JF: 1985. The functional role of zinc in angiotensin converting enzyme: implications for the enzyme mechanism. J Inorg Biochem 24:183-198.
8. Capecchi MR: 1989. Altering the genome by homologous recombination. Science 244: 1288-1292.
9. Chai S-Y, Mendelsohn FAO, Paxinos G: 1987. Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography. Neuroscience 20:615-627.
10. Corvol P, Williams TA, Soubrier F: 1995. Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enzymol 248:283-305.
11. Cushman DW, Cheung HS: 1972. Studies in vitro of angiotensin-converting enzyme of lung and other tissues. In Genest J, Koiw E, eds. Hypertension Nineteen Seventy-Two: Proceedings. New York, Springer-Verlag, pp 532-541.
12. Delmas V, Sassone-Corsi P: 1994. The key role of CREM in the cAMP signaling pathway in the testis. Mol Cell Endocrinol 100:121-124.
13. Dostal LA, Kim SN, Schardein JL, Anderson JA: 1991. Fertility and perinatal/postnatal studies in rats with the angiotensin-converting enzyme inhibitor, quinapril. Fundam Appl Toxicol 17:684-695.
14. Ehlers MR, Fox EA, Strydom DJ, Riordan JF: 1989. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci USA 86:7741-7745.
15. Esther CR Jr, Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE: 1996. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology and reduced male fertility. Lab Invest 74:953-965.
16. Esther CR Jr., Marino EM, Howard TE, Corvol P, Capecchi MR, Bernstein KE. 1997. The critical role of tissue angiotensin converting enzyme (ACE) as revealed by gene targeting in mice. J Clin Invest 99:2375-2385.
17. Foresta C, Mioni R, Rossato M, Varotto A, Zorzi M: 1991. Evidence for the involvement of sperm angiotensin converting enzyme in fertilization. Int J Androl 14:333-339.
18. Goldblatt H, Lynch J, Hanzal RF, Summerville WW: 1934. Studies on experimental hypertension. I. The production and persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59:347-380.
19. Howard TE, Shai S-Y, Langford KG, Martin BM, Bernstein KE: 1990. Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene. Mol Cell Biol 10:4294-4302.
20. Howard TE, Balogh R, Overbeek P, Bernstein KE: 1992. Sperm specific expression of angiotensin-converting enzyme (ACE) is mediated by a 91 base pair promoter encoding a CRE-like element. Mol Cell Biol 13:18-27.
21. Hubert C, Houot A-M, Corvol P, Soubrier P: 1991. Structure of the angiotensin I-converting enzyme gene. J Biol Chem 266:15,377-15,383.
22. Ito M, Oliverio MI, Mannon PJ, et al.: 1995. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92:3521-3525.
23. Jackson B, Cubela RB, Sakaguchi K, Johnston CI: 1988. Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril. Endocrinology 123:50-55.
24. Jaspard E, Wei L, Alhenc-Gelas F: 1993. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II): studies with bradykinin and other natural peptides. J Biol Chem 268:9496-9503.
25. Kim HS, Krege JH, Kluckman KD, et al.: 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92:2735-2739.
26. Krege JH, John SWM, Langenbach LL, et al.: 1995. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-148.
27. Kumar RS, Kusari J, Roy SN, Soffer RL, Sen GC: 1989. Structure of testicular angiotensin converting enzyme: a segmental mosaic isozyme. J Biol Chem 264:16,754-16,758.
28. Langford KG, Shai S-Y, Howard TE, Kovac MJ, Overbeek PA, Bernstein KE: 1991. Transgenic mice demonstrate a testis specific promoter for angiotensin converting enzyme (ACE). J Biol Chem 266:15,559-15,562.
29. Lattion AL, Soubrier F, Allegrinin J, Hubert C, Corvol P, Alhenc-Gelas F: 1989. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett 252:99-104.
30. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: 1993. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: the collaborative study group. N Engl J Med 329:1456-1462.
31. Minsker DH, Bagdon WJ, MacDonald JS, Robertson RT, Bokelman DL: 1990. Maternotoxicity and fetotoxicity of an angiotensin-converting enzyme inhibitor, enalapril, in rabbits. Fundam Appl Toxicol 14:461-470.
32. Nantel F, Monaco L, Foulkes NS, et al.: 1996. Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice. Nature 380: 159-162.
33. Nimura F, Labosky PA, Kakuchi J, et al: 1996. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96: 2947-2954.
34. Ondetti MA, Rubin B, Cushman DW 1977. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active anti-hypertensive agents. Science 196:441-444.
35. Pickering GW, Prinzmetal M: 1938. Some observations on renin, a pressor substance contained in normal kidney, together with a method for its biological assay. Clin Sci 3:211-227.
36. Rousseau A, Michaud A, Chauvet MT, Lenfant M, Corvol P: 1995. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem 270:3656-3661.
37. Sakaguchi K, Jackson B, Chai SY, Mendelsohn FA, Johnson CI: 1988. Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography. J Cardiovasc Pharmacol 12: 710-717.
38. Semple PF: 1995. Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitors. J Hypertens 3(Suppl):S17-21.
39. Skeggs LT: 1993. Discovery of the two angiotensin peptides and the angiotensin converting enzyme. Hypertension 21:259-260.
40. Skeggs LT, Kahn JR, Shumway NP: 1956a. The purification of hypertensin-II. J Exp Med 103:301-307.
41. Skeggs LT, Kahn JR, Shumway NP: 1956b. The preparation and function of the hypertensin-converting enzyme. J Exp Med 103:295-297.
42. 2-and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 82:1025-1029.
43. Skidgel RA, Engelbrecht S, Johnson AR, Erdos EG: 1984. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 5:769-776.
44. Sibony M, Gasc JM, Soubrier F, Alhenc-Gelas F, Corvol P: 1993. Gene expression and tissue localization of the two isoforms of angiotensin I-converting enzyme. Hypertension 21:827-835.
45. Soubrier F, Alhenc-Gelas F, Hubert C, et al.: 1988. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85:9386-9390.
46. Swales JD: 1994. The renin-angiotensin system as a target for therapeutic intervention. J Cardiovasc Pharmacol 24(Suppl):S1-S5.
47. Takada Y, Hiwada K, Akatsu H, Hashimoto A, Kokubu T: 1984. The immunocytochemical detection of angiotensin converting enzyme in alveolar macrophages from patients with sarcoidosis. Lung 162:317-323.
48. Tanimoto K, Sugiyama F, Goto Y, et al.: 1994. Angiotensinogen-deficient mice with hypotension. J Biol Chem 269:31,334-31,337.
49. Tigerstedt R, Bergman PG: 1898. Niere und Kreislauf. Scand Arch Physiol 7-8:223-271.
50. Vinson GP, Puddefoot JR, Ho MM, et al.: 1995. Type 1 angiotensin II (AT1) receptors in sperm. J Endocrinol 144:369-378.
51. Weare JA, Gafford JT, Lu HS, Erdos EG: 1982. Purification of human kidney angiotensin I converting enzyme using reverse immunoabsorption chromatography. Anal Biochem 123:310-319.
52. Wei L, Alhenc-Gelas F, Corvol P, Clauser E: 1991. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 266: 9002-9008.
53. Williams GH: 1988. Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med 319:1517-1525.
54. Zhou Y, Delafontaine P, Martin BM, Bernstein KE: 1995. Identification of two positive transcriptional elements within the 91-base pair promoter for mouse testis angiotensin converting enzyme (testis ACE). Dev Genet 16: 201-209.
55. Zhou Y, Overbeek PA, Bernstein KE: 1996a. Tissue specific expression of testis angiotensin converting enzyme is not determined by the -32 nonconsensus TATA motif. Biochem Biophys Res Commun 223:48-53.
56. Zhou Y, Sun Z, Means AR, Sassone-Corsi P, Bernstein KE: 1996b. CREMτ is a positive regulator of testis ACE transcription. Proc Natl Acad Sci USA 93:12,262-12,266.